Engineers at Brown University have designed a biological device that can measure glucose concentrations in human saliva. The technique could eliminate the need for diabetics to draw blood to check their glucose levels. The biochip uses plasmonic interferometers and could be used to measure a range of biological and environmental substances.
Researchers from the University at Buffalo, Army Research Laboratory and Air Force Office of Scientific Research have developed a new, nanomaterials-based technology that has the potential to increase the efficiency of photovoltaic cells up to 45 percent.
University of Notre Dame nuclear physicists Philippe Collon and Michael Wiescher are using accelerated ion beams to pinpoint the age and origin of material used in pottery, painting, metalwork and other art. The results of their tests can serve as powerful forensic tools to reveal counterfeit art work, without the destruction of any sample as required in some chemical analysis.
The fourth conference in the Twente Mastership series will be held at the University of Twente on Thursday 26 January. This conference is intended to build bridges between secondary and higher education. The theme of the conference is "from research to teaching concept".
Scientists who have developed a new way to create a type of radiation known as Terahertz (THz) or T-rays say their new, stronger and more efficient continuous wave T-rays could be used to make better medical scanning gadgets and may one day lead to innovations similar to the "tricorder" scanner used in Star Trek.
To overcome a built-in mechanism that makes tumors resistant to radiation resistance, researchers have developed a nanoparticle formulation that interferes with the resistance mechanism, and as a result, increases the efficacy of radiation therapy in a mouse model of head and neck cancer.
Researchers at Harvard Medical School and the Massachusetts Institute of Technology have developed a strategy for identifying what could be called tumor uptake molecules for use on nanoparticles. This new class of tumor-targeting agents boosts the amount of drug-loaded nanoparticles that get into cancer cells.